SARS-CoV-2 associated Guillain–Barré syndrome
Tóm tắt
Presented herein is a severe case of SARS-CoV-2 associated Guillain–Barré syndrome (GBS), showing only slight improvement despite adequate therapy. To date, only few cases of GBS associated with this infection have been described. This case report summarizes the insights gain so far to GBS with this antecedent trigger. So far, attention has mostly focused on complications of the CNS involvement. Taking into account that GBS can cause a considerable impairment of the respiratory system, clinicians dealing with SARS-CoV-2 positive-tested patients should pay attention to symptoms of the peripheral nervous system. As far as we know from this reported case and the review of the current literature, there seems to be no association with antiganglioside antibodies or a positive SARS-CoV-2 RT-PCR in CSF. An obvious frequent occurrence of a bilateral facial weakness or bilateral peripheral facial diplegia should be emphasized.
Tài liệu tham khảo
Wu Y, Wua Y, Xuc X, Chenb Z, Duanb J, Hashimotod K et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.03.031
Mao L, Wang MD, Chen SH, He QW, Chang J, Hong CD, et al. (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv 2020.02.22.20026500.
Yuki N, Hartung HP (2012) Guillain-Barré syndrome. N Engl J Med 366:2294–2304
Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27:S21–S24
Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI et al (1998) The spectrum of antecedent infections in Guillain–Barré syndrome: a case-control study. Neurology 51(4):1110–5
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 395(10223):497–506
Grimm A, Décard BF, Schramm A, Pröbstel AK, Rasenack M et al (2016) Ultrasound and electrophysiologic findings in patients with Guillain–Barré syndrome at disease onset and over a period of 6 months. Clin Neurophysiol 127(2):1657–1663
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P et al (2020) Guillain–Barré syndrome associated with SARS-CoV-2. N Engl J Med. https://doi.org/10.1056/NEJMc2009191
Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2020.04.062
Zhao H, Shen D, Zhou H, Liu J, Chen S. (2020) Guillain–Barré syndrome associated with SARSCoV-2 infection: causality or coincidence? https://doi.org/10.1016/S1474-4422(20)30109-5
Virani A, Rabold E, Hanson T, Haag A, Elrufay R et al (2020) Guillain-Barré Syndrome associated with SARS-CoV-2 infection. IDCases. https://doi.org/10.1016/j.idcr.2020.e00771
May M (1986) The facial nerve, chapter 9. Thieme Inc, New York, p 181